EcoDrugPlus

Adrenoceptor Beta 3a

Ensembl ID : ENSLCAG00010027634
Gene Symbol: ADRB3A
4 Cross references
196 Possible Orthologues:

Aldo-Keto Reductase Family 1, Member B1 (Aldose Reductase), Tandem Duplicate 1

Ensembl ID : ENSLCAG00010026890
Gene Symbol: AKR1B1.1
1 Cross references
345 Possible Orthologues:

Aldo-Keto Reductase Family 1, Member B1 (Aldose Reductase), Tandem Duplicate 2

Ensembl ID : ENSLCAG00010026898
Gene Symbol: AKR1B1.2
1 Cross references
343 Possible Orthologues:

Alpha Glucosidase

Ensembl ID : ENSLCAG00010012965
Gene Symbol: GAA
2 Cross references
233 Possible Orthologues:

Alpha Glucosidase

Ensembl ID : ENSLCAG00010013148
Gene Symbol: GAA
4 Cross references
233 Possible Orthologues:

Alpha-2b Adrenergic Receptor

Ensembl ID : ENSLCAG00010023857
Gene Symbol: LOC108895898
4 Cross references
149 Possible Orthologues:

Alpha-Synuclein

Ensembl ID : ENSLCAG00010005953
Gene Symbol: LOC108874055
3 Cross references
189 Possible Orthologues:

Amine Oxidase Copper Containing 1

Ensembl ID : ENSLCAG00010001494
Gene Symbol: LOC108881560
4 Cross references
231 Possible Orthologues:

Amine Oxidase Copper Containing 2

Ensembl ID : ENSLCAG00010009030
Gene Symbol: AOC2
1 Cross references
403 Possible Orthologues:

Amylase Alpha 1c

Ensembl ID : ENSLCAG00010021283
Gene Symbol: AMY1C
4 Cross references
213 Possible Orthologues:

Amyloid Beta (A4) Precursor Protein B

Ensembl ID : ENSLCAG00010023089
Gene Symbol: APPB
1 Cross references
204 Possible Orthologues:

Amyloid Beta Precursor Protein

Ensembl ID : ENSLCAG00010026969
Gene Symbol: APP
2 Cross references
203 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).